WO2001038565A3 - Oligomer-array mit pna- und/oder dna-oligomeren auf einer oberfläche - Google Patents

Oligomer-array mit pna- und/oder dna-oligomeren auf einer oberfläche Download PDF

Info

Publication number
WO2001038565A3
WO2001038565A3 PCT/DE2000/004301 DE0004301W WO0138565A3 WO 2001038565 A3 WO2001038565 A3 WO 2001038565A3 DE 0004301 W DE0004301 W DE 0004301W WO 0138565 A3 WO0138565 A3 WO 0138565A3
Authority
WO
WIPO (PCT)
Prior art keywords
oligomers
general formula
pna
dna oligomers
oligomer array
Prior art date
Application number
PCT/DE2000/004301
Other languages
English (en)
French (fr)
Other versions
WO2001038565A2 (de
Inventor
Kurt Berlin
Original Assignee
Epigenomics Ag
Kurt Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP00993178A priority Critical patent/EP1232287B1/de
Priority to DK00993178T priority patent/DK1232287T3/da
Priority to AU28270/01A priority patent/AU784238B2/en
Priority to IL14980100A priority patent/IL149801A0/xx
Application filed by Epigenomics Ag, Kurt Berlin filed Critical Epigenomics Ag
Priority to CN008161941A priority patent/CN1413263B/zh
Priority to MXPA02005221A priority patent/MXPA02005221A/es
Priority to CA2390312A priority patent/CA2390312C/en
Priority to NZ51854800A priority patent/NZ518548A/xx
Priority to US10/148,140 priority patent/US6936419B1/en
Priority to JP2001539907A priority patent/JP2003514570A/ja
Priority to SI200030961T priority patent/SI1232287T1/sl
Priority to DE50014333T priority patent/DE50014333D1/de
Publication of WO2001038565A2 publication Critical patent/WO2001038565A2/de
Publication of WO2001038565A3 publication Critical patent/WO2001038565A3/de
Priority to IS6364A priority patent/IS2445B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips

Abstract

Beschrieben wird ein Oligomer-Array mit PNA- (Peptide Nucleic Acids)- und/oder DNA-Oligomeren auf einer Oberfläche, umfassend Oligomere aus jeweils zwischen 6 und 20 Monomeren oder Nukleobasen, wobei diese jeweils mindestens eine Sequenz der allgemeinen Formel DDCGDD oder der allgemeinen Formel DDTGDD oder der allgemeinen Formel HHCGHH oder der allgemeinen Formel HHCAHH umfassen,wobeiH eine der Basen Adenin (A), Cytosin (C) oder Thymin (T) bedeutet undD eine der Basen Adenin (A), Guanin (G) oder Thymin (T) darstellt,und wobei der Ort der Oligomere auf der Oberfläche mit der Sequenz der Oligomere korreliert ist.Die erfindungsgemäßen Oligomar-Arrays werden zur Detektion von Cytosin-Methylierungen in genomischer DNA verwendet.
PCT/DE2000/004301 1999-11-25 2000-11-24 Oligomer-array mit pna- und/oder dna-oligomeren auf einer oberfläche WO2001038565A2 (de)

Priority Applications (13)

Application Number Priority Date Filing Date Title
MXPA02005221A MXPA02005221A (es) 1999-11-25 2000-11-24 Arreglo de oligomeros con oligomeros de adn y/o adn sobre una superficie.
AU28270/01A AU784238B2 (en) 1999-11-25 2000-11-24 Oligomer array with PNA and/or DNA oligomers on a surface
IL14980100A IL149801A0 (en) 1999-11-25 2000-11-24 Oligomer array with pna and/or dna oligomers on a surface
NZ51854800A NZ518548A (en) 1999-11-25 2000-11-24 Oligomer array with PNA and/or DNA oligomers on a surface
CN008161941A CN1413263B (zh) 1999-11-25 2000-11-24 表面上带有pna和/或dna寡聚物的寡聚物阵列
DK00993178T DK1232287T3 (da) 1999-11-25 2000-11-24 Oligomer array med PNA og/eller DNA-oligomerer på en overflade
CA2390312A CA2390312C (en) 1999-11-25 2000-11-24 Oligomer array with pna and/or dna oligomers on a surface
EP00993178A EP1232287B1 (de) 1999-11-25 2000-11-24 Oligomer-array mit pna- und/oder dna-oligomeren auf einer oberfläche
US10/148,140 US6936419B1 (en) 1999-11-25 2000-11-24 Oligomer array with PNA and/or DNA oligomers on a surface
JP2001539907A JP2003514570A (ja) 1999-11-25 2000-11-24 表面上においてｐｎａ−および／またはｄｎａ−オリゴマーを用いたオリゴマー配列
SI200030961T SI1232287T1 (sl) 1999-11-25 2000-11-24 Oligomerna mreža s PNA- in/ali DNA-oligomeri na površini
DE50014333T DE50014333D1 (de) 1999-11-25 2000-11-24 Oligomer-array mit pna- und/oder dna-oligomeren auf einer oberfläche
IS6364A IS2445B (is) 1999-11-25 2002-04-26 Fáliðu fylki með PNA og/eða DNA fáliður á yfirborði.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19957827A DE19957827C2 (de) 1999-11-25 1999-11-25 Verwendung eines Oligomer-Arrays mit PNA- und/oder DNA-Oligomeren auf einer Oberfläche
DE19957827.3 1999-11-25

Publications (2)

Publication Number Publication Date
WO2001038565A2 WO2001038565A2 (de) 2001-05-31
WO2001038565A3 true WO2001038565A3 (de) 2001-11-15

Family

ID=7930999

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2000/004301 WO2001038565A2 (de) 1999-11-25 2000-11-24 Oligomer-array mit pna- und/oder dna-oligomeren auf einer oberfläche

Country Status (16)

Country Link
US (1) US6936419B1 (de)
EP (2) EP1232287B1 (de)
JP (2) JP2003514570A (de)
CN (1) CN1413263B (de)
AT (1) ATE362548T1 (de)
AU (1) AU784238B2 (de)
CA (1) CA2390312C (de)
DE (2) DE19957827C2 (de)
DK (1) DK1232287T3 (de)
ES (1) ES2287049T3 (de)
IL (1) IL149801A0 (de)
IS (1) IS2445B (de)
MX (1) MXPA02005221A (de)
NZ (1) NZ518548A (de)
PT (1) PT1232287E (de)
WO (1) WO2001038565A2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001247414A1 (en) 2000-03-14 2001-09-24 Active Motif Oligonucleotide analogues, methods of synthesis and methods of use
AUPR142500A0 (en) * 2000-11-13 2000-12-07 Human Genetic Signatures Pty Ltd A peptide nucleic acid-based assay for the detection of specific nucleic acid sequences
DE10142643A1 (de) * 2001-08-31 2003-04-24 Clondiag Chip Tech Gmbh Detektion von Wechselwirkungen auf Sonden-Arrays
DE10145226A1 (de) * 2001-09-13 2003-04-10 Lifebits Ag Herstellung von trägergebundenen Molekülen
US20110151438A9 (en) 2001-11-19 2011-06-23 Affymetrix, Inc. Methods of Analysis of Methylation
US7238518B2 (en) * 2002-10-04 2007-07-03 Nisshinbo Industries, Inc. Oligonucleotide-immobilized substrate for detecting methylation
DE602004028478D1 (de) 2003-06-17 2010-09-16 Human Genetic Signatures Pty Verfahren zur genomamplifikation
EP1668148B1 (de) 2003-09-04 2008-12-31 Human Genetic Signatures PTY Ltd. Nukleinsäurenachweistest
US20050196792A1 (en) * 2004-02-13 2005-09-08 Affymetrix, Inc. Analysis of methylation status using nucleic acid arrays
US8168777B2 (en) 2004-04-29 2012-05-01 Human Genetic Signatures Pty. Ltd. Bisulphite reagent treatment of nucleic acid
DK1794173T3 (da) 2004-09-10 2010-10-25 Human Genetic Signatures Pty Amplifikationsblokker indeholdende interkalaterende nukleinsyrer (INA) indeholdende interkalaterende pseudonukleotider (IPN)
EP1794319B1 (de) 2004-09-30 2014-08-13 Epigenomics AG Verfahren zur bereitstellung von dna-fragmenten aus einer archivierten probe
CN101111606B (zh) 2004-12-03 2012-05-16 人类遗传标记控股有限公司 通过化学修饰胞嘧啶而简化微生物核酸的方法
EP1693468A1 (de) 2005-02-16 2006-08-23 Epigenomics AG Verfahren zur Bestimmung des Methylierungsmusters einer Polynukleinsäure
EP1871912B1 (de) 2005-04-15 2012-02-29 Epigenomics AG Verfahren zur Bestimmung der DNA-Methylierung in Blut- oder Urinproben
CN101203618B (zh) 2005-05-26 2013-03-13 人类遗传标记控股有限公司 使用含有非常规碱基的引物的等温链置换扩增
US8343738B2 (en) 2005-09-14 2013-01-01 Human Genetic Signatures Pty. Ltd. Assay for screening for potential cervical cancer
KR101211747B1 (ko) 2005-09-22 2012-12-12 이데미쓰 고산 가부시키가이샤 산화물 재료 및 스퍼터링 타겟
EP1969139A1 (de) 2005-11-17 2008-09-17 Epigenomics AG Verfahren zur bestimmung des dna-methylierungsniveaus einer cpg-position in identischen zellen in einer gewebeprobe
US7901882B2 (en) 2006-03-31 2011-03-08 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
JP5244103B2 (ja) 2006-08-09 2013-07-24 ホームステッド クリニカル コーポレイション 器官特異的蛋白質およびその使用方法
EP2479289B1 (de) 2007-06-08 2016-04-06 Epigenomics AG Verfahren zur Methylierungsanalyse
US8685675B2 (en) 2007-11-27 2014-04-01 Human Genetic Signatures Pty. Ltd. Enzymes for amplification and copying bisulphite modified nucleic acids
ES2742251T3 (es) 2009-03-16 2020-02-13 Pangu Biopharma Ltd Composiciones y procedimientos que comprenden variantes de splicing de histidil-tarn sintetasa que tienen actividades biológicas no canónicas
CA2757289A1 (en) 2009-03-31 2010-10-21 Atyr Pharma, Inc. Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
WO2011139714A2 (en) 2010-04-26 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
CN103096911B (zh) 2010-04-27 2018-05-29 Atyr 医药公司 与异亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
WO2011139853A2 (en) 2010-04-28 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
WO2011150279A2 (en) 2010-05-27 2011-12-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
CN103097523B (zh) 2010-04-29 2016-09-28 Atyr医药公司 与天冬酰胺酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
AU2011248457B2 (en) 2010-04-29 2017-02-16 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases
US8981045B2 (en) 2010-05-03 2015-03-17 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-tRNA synthetases
US8961961B2 (en) 2010-05-03 2015-02-24 a Tyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases
CN105820252B (zh) 2010-05-03 2020-07-21 Atyr 医药公司 与苯丙氨酰-α-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
CA2798139C (en) 2010-05-04 2019-09-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
CN103200953B (zh) 2010-05-14 2017-02-15 Atyr 医药公司 与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
AU2011256366C1 (en) 2010-05-17 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
EP2575857B1 (de) 2010-06-01 2018-01-24 aTyr Pharma, Inc. Innovative erkennung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen in zusammenhang mit proteinfragmenten von lysyl-trna-synthetasen
AU2011289831C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
CN103108650A (zh) 2010-08-25 2013-05-15 Atyr医药公司 与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
MY167564A (en) 2011-09-07 2018-09-14 Human Genetic Signatures Pty Ltd Molecular detection assay
EP3311847A1 (de) 2012-02-16 2018-04-25 Atyr Pharma, Inc. Histidyl-trna-synthetasen zur behandlung von autoimmun- und entzündungserkrankungen
MX367366B (es) 2012-11-27 2019-08-16 Univ Pontificia Catolica Chile Composiciones y metodos para diagnosticar tumores de tiroides.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025563A1 (en) * 1992-06-17 1993-12-23 City Of Hope A method of detecting and discriminating between nucleic acid sequences
WO1997046705A1 (en) * 1996-06-03 1997-12-11 The Johns Hopkins University School Of Medicine Methylation specific detection
WO1999028498A2 (de) * 1997-11-27 1999-06-10 Epigenomics Gmbh Verfahren zur herstellung komplexer dna-methylierungs-fingerabdrücke
WO2001027317A2 (de) * 1999-10-15 2001-04-19 Epigenomics Ag Verfahren zur unterscheidung von 5-position methylierungsänderungen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695926A (en) * 1990-06-11 1997-12-09 Bio Merieux Sandwich hybridization assays using very short capture probes noncovalently bound to a hydrophobic support
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5824473A (en) * 1993-12-10 1998-10-20 California Institute Of Technology Nucleic acid mediated electron transfer
US5589330A (en) * 1994-07-28 1996-12-31 Genzyme Corporation High-throughput screening method for sequence or genetic alterations in nucleic acids using elution and sequencing of complementary oligonucleotides
US5514551A (en) * 1994-10-14 1996-05-07 Gen-Probe Incorporated Compositions for the detection of Chlamydia trachomatis
GB9620769D0 (en) * 1996-10-04 1996-11-20 Brax Genomics Ltd Nucleic acid sequencing
DK0937096T3 (da) * 1996-11-06 2004-06-14 Sequenom Inc Fremgangsmåde til massespektrometri-analyse
GB9707980D0 (en) * 1997-04-21 1997-06-11 Brax Genomics Ltd Characterising DNA
AU742599B2 (en) * 1997-07-22 2002-01-10 Qiagen Genomics, Inc. Multiple functionalities within an array element and uses thereof
CN1265156A (zh) * 1997-07-22 2000-08-30 拉普吉恩公司 核酸阵列上进行的扩增及其它酶反应
DK1036202T3 (da) * 1997-12-05 2002-08-12 Max Planck Gesellschaft Fremgangsmåde til identifikation af nucleinsyrer ved matriksassisteret laserdesorptions/ionisationsmassespektrometri
WO1999029897A1 (de) * 1997-12-05 1999-06-17 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur identifikation von nucleinsäuren durch elektrospray massenspektrometrie
DE69921982T2 (de) * 1998-04-30 2005-12-29 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Neuartiges verfahren zur identifizierung von klonen mit einer gewünschten biologischen eigenschaft, ausgehend von einer expressionsgenbank
US6048695A (en) * 1998-05-04 2000-04-11 Baylor College Of Medicine Chemically modified nucleic acids and methods for coupling nucleic acids to solid support
US6664045B1 (en) * 1998-06-18 2003-12-16 Boston Probes, Inc. PNA probes, probe sets, methods and kits pertaining to the detection of microorganisms
US6605432B1 (en) * 1999-02-05 2003-08-12 Curators Of The University Of Missouri High-throughput methods for detecting DNA methylation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025563A1 (en) * 1992-06-17 1993-12-23 City Of Hope A method of detecting and discriminating between nucleic acid sequences
WO1997046705A1 (en) * 1996-06-03 1997-12-11 The Johns Hopkins University School Of Medicine Methylation specific detection
WO1999028498A2 (de) * 1997-11-27 1999-06-10 Epigenomics Gmbh Verfahren zur herstellung komplexer dna-methylierungs-fingerabdrücke
WO2001027317A2 (de) * 1999-10-15 2001-04-19 Epigenomics Ag Verfahren zur unterscheidung von 5-position methylierungsänderungen

Also Published As

Publication number Publication date
CN1413263B (zh) 2012-07-04
CA2390312A1 (en) 2001-05-31
AU2827001A (en) 2001-06-04
IL149801A0 (en) 2002-11-10
DE19957827A1 (de) 2001-06-21
ES2287049T3 (es) 2007-12-16
IS2445B (is) 2008-11-15
EP1816216A2 (de) 2007-08-08
ATE362548T1 (de) 2007-06-15
PT1232287E (pt) 2007-08-21
DK1232287T3 (da) 2007-09-24
EP1232287B1 (de) 2007-05-16
NZ518548A (en) 2004-12-24
WO2001038565A2 (de) 2001-05-31
DE50014333D1 (de) 2007-06-28
JP2003514570A (ja) 2003-04-22
EP1232287A2 (de) 2002-08-21
DE19957827C2 (de) 2003-06-12
IS6364A (is) 2002-04-26
AU784238B2 (en) 2006-02-23
EP1816216A3 (de) 2009-06-03
CN1413263A (zh) 2003-04-23
JP2007175051A (ja) 2007-07-12
CA2390312C (en) 2011-05-31
US6936419B1 (en) 2005-08-30
MXPA02005221A (es) 2004-08-23

Similar Documents

Publication Publication Date Title
WO2001038565A3 (de) Oligomer-array mit pna- und/oder dna-oligomeren auf einer oberfläche
CA2278715A1 (en) Aminooxy-modified oligonucleotides
IL102765A (en) Reagents and methods to detect and determine mycobacterium nucleic acids
WO2004042029A3 (en) Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use
ES2192672T3 (es) Nuevos analogos de nucleotidos.
DK0800587T3 (da) Komparativ hybridisering af nukleinsyrerækker
ATE501269T1 (de) Detektion von genmutationen mittels lna primer
WO2002018631A3 (de) Diagnose von bestehenden erkrankungen oder der prädisposition für bestimmte erkrankungen
WO2001042493A3 (de) Verfahren zur parallelen detektion des methylierungszustandes von genomischer dna
DE60112746D1 (de) Kälteempfindliche dna-polymerasemutanten
WO2002000928A3 (de) Diagnose von mit dem immunsystem assoziierten krankheiten durch bestimmung der cytosin-methylierung
CA2310077A1 (en) De novo or "universal" sequencing array
WO2003052133A3 (en) Oligonucleotide analogues comprising intercalator pseudonucleotides
CA2195971A1 (en) Nucleic acid hybridization assay probes targeted to mycoplasma pneumoniae nucleic acid
CA2485596A1 (en) Pyrophosphorolysis activated polymerization (pap)
EP1312685A3 (de) Oligonukleotidarray zum Nachweis von Methylierungszuständen
WO2000022171A3 (en) Systems and methods for sequencing by hybridization
DE69917636D1 (en) Polymerasesignalversuch
EP1201769A3 (de) Universelle Arrays zur Beobachtung der Genexpression
WO1990009457A3 (en) Oligonucleotide primer pairs for sequence independent gene amplification and methods which employ them
WO2001038351A3 (en) Nucleotide sequence of the shrimp white spot syndrome bacilliformvirus (wsbv), systems containing this sequence and detection kits
CA2442438A1 (en) Oligonucleotide-immobilized substrate for detecting methylation
EP1577318A4 (de) Nukleotidderivate und dna-mikroarray
CA2289961A1 (en) A gene causative of rheumatoid arthritis, method for diagnosing rheumatoid arthritis, and method for identifying causative factors of rheumatoid arthritis
JP2004504028A5 (de)

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2001 539907

Country of ref document: JP

Kind code of ref document: A

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WD Withdrawal of designations after international publication

Free format text: DE

WWE Wipo information: entry into national phase

Ref document number: 518548

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2000993178

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 149801

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2390312

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/005221

Country of ref document: MX

Ref document number: 008161941

Country of ref document: CN

Ref document number: 28270/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 10148140

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2000993178

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 518548

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 518548

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 2000993178

Country of ref document: EP